EKEN, A. Et Al. 2020. Schisandrin B and Alantolactone ameliorates experimental autoimmune encephalomyelitis in mice. The Journal of Immunology , 16012.

EKEN, A., ÇAKIR, M., KARAYİĞİT, M. Ö., & ALTUNTAŞ, H., (2020). Schisandrin B and Alantolactone ameliorates experimental autoimmune encephalomyelitis in mice . The Journal of Immunology (pp.16012).

EKEN, AHMET Et Al. "Schisandrin B and Alantolactone ameliorates experimental autoimmune encephalomyelitis in mice," The Journal of Immunology, 2020

EKEN, AHMET Et Al. "Schisandrin B and Alantolactone ameliorates experimental autoimmune encephalomyelitis in mice." The Journal of Immunology , pp.16012, 2020

EKEN, A. Et Al. (2020) . "Schisandrin B and Alantolactone ameliorates experimental autoimmune encephalomyelitis in mice." The Journal of Immunology , p.16012.

@conferencepaper{conferencepaper, author={AHMET EKEN Et Al. }, title={Schisandrin B and Alantolactone ameliorates experimental autoimmune encephalomyelitis in mice}, congress name={The Journal of Immunology}, city={}, country={}, year={2020}, pages={16012} }